These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31606083)

  • 21. Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activity.
    Farley K; Mett H; McGlynn E; Murray B; Lydon NB
    Anal Biochem; 1992 May; 203(1):151-7. PubMed ID: 1381873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abl-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukaemic cell adhesion.
    Maruoka M; Sato M; Yuan Y; Ichiba M; Fujii R; Ogawa T; Ishida-Kitagawa N; Takeya T; Watanabe N
    Biochem J; 2012 Feb; 441(3):889-99. PubMed ID: 22014333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.
    Lin J; Sun T; Ji L; Deng W; Roth J; Minna J; Arlinghaus R
    Oncogene; 2007 Oct; 26(49):6989-96. PubMed ID: 17486070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation.
    Baskaran R; Escobar SR; Wang JY
    Cell Growth Differ; 1999 Jun; 10(6):387-96. PubMed ID: 10392900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection.
    Lin M; den Dulk-Ras A; Hooykaas PJ; Rikihisa Y
    Cell Microbiol; 2007 Nov; 9(11):2644-57. PubMed ID: 17587335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe.
    Walkenhorst J; Goga A; Witte ON; Superti-Furga G
    Oncogene; 1996 Apr; 12(7):1513-20. PubMed ID: 8622867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
    Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
    Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Abl tyrosine kinase regulates c-fos gene expression via phosphorylating RNA polymerase II.
    Jing Y; Song Z; Wang M; Tang W; Hao S; Zeng X
    Arch Biochem Biophys; 2005 May; 437(2):199-204. PubMed ID: 15850559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The substrate specificity of the catalytic domain of Abl plays an important role in directing phosphorylation of the adaptor protein Crk.
    Amoui M; Miller WT
    Cell Signal; 2000 Oct; 12(9-10):637-43. PubMed ID: 11080615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases.
    Torres M; Hall FL; O'Neill K
    J Immunol; 1993 Feb; 150(4):1563-77. PubMed ID: 7679431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth.
    Zukerberg LR; Patrick GN; Nikolic M; Humbert S; Wu CL; Lanier LM; Gertler FB; Vidal M; Van Etten RA; Tsai LH
    Neuron; 2000 Jun; 26(3):633-46. PubMed ID: 10896159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
    Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14.
    Sanguinetti AR; Mastick CC
    Cell Signal; 2003 Mar; 15(3):289-98. PubMed ID: 12531427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
    Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
    Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
    Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
    Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
    Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A colorimetric enzyme-linked on-bead assay for identification of synthetic substrates of protein tyrosine kinases.
    Martin SE; Peterson BR
    J Pept Sci; 2002 May; 8(5):227-33. PubMed ID: 12043997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.